259 related articles for article (PubMed ID: 15496154)
1. C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.
Rangan GK; Pippin JW; Couser WG
Kidney Int; 2004 Nov; 66(5):1838-48. PubMed ID: 15496154
[TBL] [Abstract][Full Text] [Related]
2. C5b-9 does not mediate chronic tubulointerstitial disease in the absence of proteinuria.
Rangan GK; Pippin JW; Coombes JD; Couser WG
Kidney Int; 2005 Feb; 67(2):492-503. PubMed ID: 15673297
[TBL] [Abstract][Full Text] [Related]
3. C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys.
Nangaku M; Pippin J; Couser WG
J Am Soc Nephrol; 2002 Apr; 13(4):928-936. PubMed ID: 11912252
[TBL] [Abstract][Full Text] [Related]
4. Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome.
Nangaku M; Pippin J; Couser WG
J Am Soc Nephrol; 1999 Nov; 10(11):2323-31. PubMed ID: 10541291
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis.
Rangan GK; Coombes JD
Nephrol Dial Transplant; 2007 Aug; 22(8):2175-82. PubMed ID: 17550925
[TBL] [Abstract][Full Text] [Related]
6. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
Wang Y; Wang YP; Tay YC; Harris DC
Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
[TBL] [Abstract][Full Text] [Related]
7. C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria.
Rangan GK
World J Nephrol; 2016 May; 5(3):288-99. PubMed ID: 27152265
[TBL] [Abstract][Full Text] [Related]
8. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
[TBL] [Abstract][Full Text] [Related]
9. Extrahepatic C6 is as effective as hepatic C6 in the generation of renal C5b-9 complexes.
Timmerman JJ; van Dixhoorn MG; Schraa EO; van Gijlswijk-Janssen DJ; Muizert Y; Van ES LA; Daha MR
Kidney Int; 1997 Jun; 51(6):1788-96. PubMed ID: 9186868
[TBL] [Abstract][Full Text] [Related]
10. Adriamycin nephropathy: a model of focal segmental glomerulosclerosis.
Lee VW; Harris DC
Nephrology (Carlton); 2011 Jan; 16(1):30-8. PubMed ID: 21175974
[TBL] [Abstract][Full Text] [Related]
11. C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis.
Hughes J; Nangaku M; Alpers CE; Shankland SJ; Couser WG; Johnson RJ
Am J Physiol Renal Physiol; 2000 May; 278(5):F747-57. PubMed ID: 10807586
[TBL] [Abstract][Full Text] [Related]
12. Induction of passive Heymann nephritis in complement component 6-deficient PVG rats.
Spicer ST; Tran GT; Killingsworth MC; Carter N; Power DA; Paizis K; Boyd R; Hodgkinson SJ; Hall BM
J Immunol; 2007 Jul; 179(1):172-8. PubMed ID: 17579035
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria is not an aggravating factor in experimental focal glomerulosclerosis and hyalinosis.
Okuda S; Oochi N; Wakisaka M; Kanai H; Tamaki K; Nagase S; Onoyama K; Fujishima M
J Lab Clin Med; 1992 Mar; 119(3):245-53. PubMed ID: 1371800
[TBL] [Abstract][Full Text] [Related]
14. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia.
Thomas SE; Anderson S; Gordon KL; Oyama TT; Shankland SJ; Johnson RJ
J Am Soc Nephrol; 1998 Feb; 9(2):231-42. PubMed ID: 9527399
[TBL] [Abstract][Full Text] [Related]
15. Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Yazdani S; Hijmans RS; Poosti F; Dam W; Navis G; van Goor H; van den Born J
Dis Model Mech; 2015 Aug; 8(8):919-30. PubMed ID: 26035383
[TBL] [Abstract][Full Text] [Related]
16. Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content.
Bertani T; Zoja C; Abbate M; Rossini M; Remuzzi G
Lab Invest; 1989 Feb; 60(2):196-204. PubMed ID: 2915514
[TBL] [Abstract][Full Text] [Related]
17. A protective role for programmed death 1 in progression of murine adriamycin nephropathy.
Qin XH; Lee VW; Wang YP; Zheng GP; Wang Y; Alexander SI; Harris DC
Kidney Int; 2006 Oct; 70(7):1244-50. PubMed ID: 16900095
[TBL] [Abstract][Full Text] [Related]
18. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.
Turnberg D; Lewis M; Moss J; Xu Y; Botto M; Cook HT
J Immunol; 2006 Sep; 177(6):4094-102. PubMed ID: 16951374
[TBL] [Abstract][Full Text] [Related]
19. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats.
Baker PJ; Ochi RF; Schulze M; Johnson RJ; Campbell C; Couser WG
Am J Pathol; 1989 Jul; 135(1):185-94. PubMed ID: 2672823
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis.
Shu Y; Hoshi S; Tomari S; Watanabe T; Nagata M
Pathol Int; 2002 Mar; 52(3):214-23. PubMed ID: 11972865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
